“Pediatric trials are difficult,” said Earl Seltzer, director, global feasibility, site and patient access, Syneos Health, at the company’s offices in Raleigh, NC.
Yet, Seltzer – who presented this week during the DIA 2018 Global Annual Meeting – said times are changing. “I think there’s more onus now on properly preparing for pediatric trials,” he said.
“Taking due diligence to properly prepare for these trials is really essential in order to be successful,” Seltzer explained.
As part of this, Seltzer said there is an increased need for transparency – as a large number of clinical trials are never completed or published.
“Regardless of if the trial is successful or not, those results are so important … people still need to learn from that.”
Transparency also is a component of improving the site investigator experience, Seltzer explained.
“Enhancing the investigator experience and giving access to new opportunities to new investigators is an important way to ensure that the future of the clinical trial landscape continues to have a healthy pipeline and pool of potential investigators to pull from,” he said.
“Transparency is a big component of this.”
Watch the video above to hear more from Seltzer on how to plan for global pediatric clinical trials and improve the site investigator experience.